Immunovant
IMVT
IMVT
194 hedge funds and large institutions have $2.76B invested in Immunovant in 2025 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 75 increasing their positions, 54 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% more funds holding in top 10
Funds holding in top 10: 6 → 8 (+2)
7.36% more ownership
Funds ownership: 54.6% → 61.96% (+7.4%)
4% more funds holding
Funds holding: 186 → 194 (+8)
Holders
194
Holding in Top 10
8
Calls
$33M
Puts
$6.57M
Top Buyers
| 1 | +$70.9M | |
| 2 | +$64.4M | |
| 3 | +$50.4M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$40.1M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$37M |
Top Sellers
| 1 | -$32.2M | |
| 2 | -$21.1M | |
| 3 | -$13.2M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$10.1M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$9.13M |
